KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,682,000 | -76.6% | 330,892 | -77.3% | 0.01% | -79.2% |
| Q3 2014 | $20,037,000 | -12.6% | 1,457,187 | -2.3% | 0.02% | -17.2% |
| Q2 2014 | $22,931,000 | -11.6% | 1,491,020 | -2.1% | 0.03% | -6.5% |
| Q1 2014 | $25,953,000 | +34.9% | 1,523,066 | +2.5% | 0.03% | +24.0% |
| Q4 2013 | $19,243,000 | +936.2% | 1,485,938 | +708.1% | 0.02% | +1150.0% |
| Q3 2013 | $1,857,000 | – | 183,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |